Medical Update Online

Late breaking abstracts – FLAURA study

The final analyses of two key trials – Checkmate 227, part 1 and FLAURA should help to position nivolumab + ipilimumab combination treatment and to

Highlights from ESMO 2019

For the second time this year, LungCancer.Med headed to Barcelona for the Annual European Society for Medical Oncology (ESMO) meeting. Written by Christine Clark

ESMO 2019 takeaways

Interview by Esther Drain In this video, Professor Solange Peters (University of Lausanne, CH) gives us her updates from ESMO including quality of research at

Encouraging data in advanced melanoma

There was a lot of great news from the ESMO Congress 2019 in Barcelona for melanoma patients. Written by Esther Drain.

IBD: the perfect example of translational medicine?

The genetic and clinical heterogeneity of IBD means translational research has a key role to play. A session dedicated to translational and basic science at

IBD healthcare and patient-reported outcomes

An oral abstract session dedicated to patient-reported outcomes (PROs) in IBD included surveys from France and the Netherlands and from the multi-centre ICONIC study.. Written

Disease monitoring in IBD – implementation in practice

Dr Maria Abreu (Miami, USA) gives us an overview of implementing disease monitoring and its challenges in clinical practice Written by Maria Dalby

Late-breaking abstracts: IBD highlights

A subcutaneous formulation of infliximab, known as CT-P13 SC, has been developed with a view to offer greater flexibility and convenience for patients.

Randomised controlled trials session

In a round-up of randomised controlled studies in IBD at UEG Week 2019 included results from the maintenance phase of the UNIFI study in UC

Welcome to International Medical Information

Our Latest News